Health & Environmental Research Online (HERO)


Print Feedback Export to File
7266421 
Meetings & Symposia 
Abstract 
Cetuximab plus 5-FU/FA/oxaliplatin (FOLFOX-4) in the first-line treatment of metastastic colorectal cancer (mCRC): a large-scale phase 11 study, OPUS 
Bokernever, C; Koralewski, P; Staroslawska, E; Makhson, A; Bondarenko, I; Hartmann, JT; Shelygin, Y; Kolesnik, O; Volovat, C; Zubel, A; , 
2007 
European Journal of Cancer Supplements
ISSN: 1359-6349 
PERGAMON-ELSEVIER SCIENCE LTD 
OXFORD 
236-236